Search fresh public links, source activity, and ready-to-use post angles for Glp-1S.
Fresh curated links around GLP-1s are collected here so marketers can spot useful updates and turn timely ideas into posts faster.
Recent items include:
Recent curated links from global sources. Generate one free draft from any story, then use SocialBu to schedule and refine your content calendar.
A once-daily GLP-1 receptor agonist decreased events of level 2 and level 3 hypoglycemia for adults after Roux-en-Y gastric bypass, according to topline results from a phase 3 tria...
Based on Danish data, the study found those on GLP-1s had 17% less long-term absences.
Based on Danish data, the study found those on GLP-1s had 17% less long-term absences.
Based on Danish data, the study found those on GLP-1s had 17% less long-term absences.
The higher-dosage GLP-1 agonists largely engendered greater cardiometabolic improvements.
The higher-dosage GLP-1 agonists largely engendered greater cardiometabolic improvements.
The benefits of GLP-1s keep adding up.
The benefits of GLP-1s keep adding up.
GLP-1 drugs, originally developed to treat diabetes and now widely used for obesity, are reshaping healthcare in the US.
For a lot of older adults, especially those carrying real cardiovascular or metabolic risk, GLP-1s may offer benefits beyond the number on the scale when under a doctor's supervisi...
New research examines the emerging benefits and unanswered questions surrounding this rapidly expanding class of medications. Millions of people are now using GLP-1 receptor agonis...
PARK CITY, Utah — When used for weight loss, previously published literature has shown GLP-1s may lead to bone resorption and muscle loss. However, a presenter here said the additi...
Are GLP-1s for life? What we know about getting older on weight-loss drugs
From unexpected babies to "Ozempic teeth," the ultra-popular class of GLP-1 medications are turning out to have a few unanticipated side effects. Emerging research shows the drugs,...
From unexpected babies to "Ozempic teeth," the ultra-popular class of GLP-1 medications are turning out to have a few unanticipated side effects. Emerging research shows the drugs,...
From unexpected babies to "Ozempic teeth," the ultra-popular class of GLP-1 medications are turning out to have a few unanticipated side effects.
GLP-1s are disrupting a healthcare system built around treating obesity-related complications, forcing providers, insurers and investors to rethink where future revenue and growth...
From unexpected babies to "Ozempic teeth," the ultra-popular class of GLP-1 medications are turning out to have a few unanticipated side effects. Emerging research shows the drugs,...
There is little debate over which Wall Street profit story is the biggest of the moment: artificial intelligence. For second-biggest, consider the case for GLP-1 drugs.
A new study establishes that GLP-1 receptor agonists significantly reduce core behavioral markers of Binge Eating Disorder, including active binge episodes, loss-of-control eating,...
You love the idea of GLP-1s like Ozempic—getting to accomplish your weight-loss goals and reap surprising bonus benefits you’ve heard about, like a lower Alzheimer’s disease risk a...
Sales of Mounjaro, Eli Lilly’s diabetes drug, rose 91 per cent in the second quarter of the year to US$9.94 billion, well above analysts' expectations.
Pre-op use of GLP-1 receptor agonists was associated with significantly improved total joint arthroplasty outcomes and risk reduction.
Dr Paul Harris – who heads up the peptide laboratory in the Biology department at Auckland University and spends his life studying and making peptides – has good reason to sound th...
Use SocialBu to discover ideas, generate post drafts, and schedule them across your social channels.